Radiolabelled PSMA PET/CT in breast cancer. A systematic review.


Journal

Nuclear medicine review. Central & Eastern Europe
ISSN: 1644-4345
Titre abrégé: Nucl Med Rev Cent East Eur
Pays: Poland
ID NLM: 100886103

Informations de publication

Date de publication:
2020
Historique:
received: 18 12 2019
accepted: 08 01 2020
entrez: 12 8 2020
pubmed: 12 8 2020
medline: 1 6 2021
Statut: ppublish

Résumé

Radiolabelled prostate-specific membrane antigen (PSMA)-based PET/CT is a whole-body imaging technique currently performed for the detection of prostate cancer lesions. PSMA has been also demonstrated to be expressed by the neovasculature of many other solid tumours. The aim of this review is to evaluate the possible diagnostic role of radiolabelled PSMA PET/CT in breast cancer. A comprehensive literature search of the PubMed/MEDLINE, Scopus, Embase and Cochrane Library databases was conducted to find relevant published articles about the diagnostic performance of radiolabelled PSMA PET/CT in breast cancer. The comprehensive computer literature search revealed 652 articles. On reviewing the titles and abstracts, 640 articles were excluded because the reported data were not within the field of interest of this review. Twelve articles were selected and retrieved in full-text version; no additional study was found when screening the references of these articles. In total, 12 articles were included in the systematic review. Further studies enrolling a wider population are needed to clarify the.

Sections du résumé

BACKGROUND BACKGROUND
Radiolabelled prostate-specific membrane antigen (PSMA)-based PET/CT is a whole-body imaging technique currently performed for the detection of prostate cancer lesions. PSMA has been also demonstrated to be expressed by the neovasculature of many other solid tumours. The aim of this review is to evaluate the possible diagnostic role of radiolabelled PSMA PET/CT in breast cancer.
MATERIAL AND METHODS METHODS
A comprehensive literature search of the PubMed/MEDLINE, Scopus, Embase and Cochrane Library databases was conducted to find relevant published articles about the diagnostic performance of radiolabelled PSMA PET/CT in breast cancer.
RESULTS RESULTS
The comprehensive computer literature search revealed 652 articles. On reviewing the titles and abstracts, 640 articles were excluded because the reported data were not within the field of interest of this review. Twelve articles were selected and retrieved in full-text version; no additional study was found when screening the references of these articles. In total, 12 articles were included in the systematic review.
CONCLUSIONS CONCLUSIONS
Further studies enrolling a wider population are needed to clarify the.

Identifiants

pubmed: 32779172
pii: VM/OJS/J/66889
doi: 10.5603/NMR.2020.0004
doi:

Substances chimiques

Antigens, Surface 0
FOLH1 protein, human EC 3.4.17.21
Glutamate Carboxypeptidase II EC 3.4.17.21

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-35

Auteurs

Francesco Bertagna (F)

University of Brescia and ASST Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123 Brescia, Italy. francesco.bertagna@unibs.it.

Domenico Albano (D)

University of Brescia and ASST Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123 Brescia, Italy.

Elisabetta Cerudelli (E)

University of Brescia and ASST Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123 Brescia, Italy.

Maria Gazzilli (M)

University of Brescia and ASST Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123 Brescia, Italy.

Davide Tomasini (D)

Department of Radiation Oncology, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.

Marco Bonù (M)

Department of Radiation Oncology, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.

Raffaele Giubbini (R)

University of Brescia and ASST Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123 Brescia, Italy.

Giorgio Treglia (G)

Department of Nuclear Medicine and PET/CT Center, Imaging Institute of Southern Switzerland, Bellinzona and Lugano, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH